According to Benzinga Pro, Krystal Biotech's peer group average for short interest as a percentage of float is 13.11%, which ...

Minimize investment losses with broad diversification. Find out how our Income Method protects your financial well-being ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...

The acquisition will also add Capstan’s proprietary tLNP platform technology, CellSeeker, which helps deliver RNA, like mRNA, ...

If you ever wondered how to maximize your success in trading with Trade X1 Serax, then you’ve landed in the right place. This article gonna unlock powerful ...

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Jyong Biotech Ltd. (Nasdaq:MENS), a biotechnology company centered on scientific development of botanical drug therapies, has marked its official listing on the Nasdaq Composite.

Remember, the biotech industry can shift very quickly, like during the COVID-19 pandemic. Be patient, do the research and don’t be afraid to exit positions that might not work well for you.

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...